Distinct transcriptional MYCN/c-MYC activities are associated with spontaneous regression or malignant progression in neuroblastomasFrank Westermann, Manfred Schwab|Genome biology|2008Cited by 271
MYCN mediates cysteine addiction and sensitizes neuroblastoma to ferroptosisHamed Alborzinia, Frank Westermann, Andrés F. Flórez et al.|Nature Cancer|2022Cited by 224
MicroRNA miR-885-5p targets CDK2 and MCM5, activates p53 and inhibits proliferation and survivalElena Afanasyeva, Frank Westermann|Cell Death and Differentiation|2011Cited by 153
Integrative Genome-Scale Analysis Identifies Epigenetic Mechanisms of Transcriptional Deregulation in Unfavorable NeuroblastomasKai-Oliver Henrich, Frank Westermann, Sebastian Bender et al.|Cancer Research|2016Cited by 125
Revised Risk Estimation and Treatment Stratification of Low- and Intermediate-Risk Neuroblastoma Patients by Integrating Clinical and Molecular Prognostic MarkersAndré Oberthuer, Matthias Fischer, Dilafruz Juraeva et al.|Clinical Cancer Research|2014Cited by 99